Healthcare

Onconova Therapeutics (NASDAQ: ONTX) CEO Interview Series

February 1, 2019 The Wall Street Analyzer Comments Off

Onconova Therapeutics (NASDAQ: ONTX) CEO: Steve Fruchtman THIS INTERVIEW HAS EXPIRED

MediXall Group (OTCQB: MDXL) CEO Interview Series

January 30, 2019 The Wall Street Analyzer Comments Off

MediXall Group (OTCQB: MDXL) CEO: Michael Swartz SVP Marketing: Vincent Caputo THIS INTERVIEW HAS EXPIRED

Citius Pharmaceuticals to Present at NobleCon15 Investor Conference

January 26, 2019 The Wall Street Analyzer Comments Off

Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at 10:00am Eastern Standard Timein Studio 2. […]

Generex Biotechnology (OTC: GNBT) CEO Interview

January 22, 2019 The Wall Street Analyzer Comments Off

Generex Biotechnology (OTC: GNBT) CEO: Joe Moscato THIS INTERVIEW HAS EXPIRED

DURECT Corporation (NASDAQ:DRRX) President and CEO: Jim Brown

December 4, 2018 The Wall Street Analyzer Comments Off

DURECT Corporation (NASDAQ:DRRX) President and CEO: Jim Brown THIS INTERVIEW HAS EXPIRED

Eyenovia, Inc (NASDAQ: EYEN) Interview with Dr. Sean Ianchulev

September 18, 2018 The Wall Street Analyzer Comments Off

Eyenovia, Inc (NASDAQ: EYEN) CEO: Dr. Sean Ianchulev THIS INTERVIEW HAS EXPIRED

Valeritas Reports Record Second Quarter Revenue with 36% Year-over-Year Growth

August 8, 2018 The Wall Street Analyzer Comments Off

Company’s Fourth Consecutive Quarter of Record Revenue and Third Consecutive Quarter with Year-Over-Year Revenue Growth Exceeding 20% […]

Contravir (NASDAQ: CTRV) Interview with CEO James Sapirstein in which he discusses recent funding and CRV431 progress

July 9, 2018 The Wall Street Analyzer Comments Off

Contravir Pharmaceuticals (NASDAQ: CTRV) CEO: James Sapirstein INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello Senior Analyst with the Wall Street Analyzer. Joining us today is James Sapirstein CEO for […]

Well Leveraged: VBI Vaccines Outlines Clinical Trial Progress

May 23, 2018 The Wall Street Analyzer Comments Off

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) — Jeff Baxter, President and CEO of VBI Vaccines Inc. (NASDAQ:VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, took time to update WSA’s investor […]

Erytech (NASDAQ: ERYP) Management Interview

May 17, 2018 The Wall Street Analyzer Comments Off

Management Interview […]

Featured Interviews

FingerMotion, Inc (NASDAQ: FNGR)

July 18, 2024 0

ABOUT: FingerMotion is an evolving technology company with a core competency in mobile payment and recharge platform solutions in China.As the user base of its primary business continues to grow, the Company is developing additional value-added technologies to market to its users. The vision of the Company is to rapidly grow the user base through organic means and have this growth develop into an ecosystem of users with high engagement rates utilizing its innovative applications. Developing a highly engaged ecosystem of users would strategically position the Company to onboard larger customer bases. FingerMotion eventually hopes to serve over 1 billion users in the China market and eventually expand the model to other regional markets. For more information on FingerMotion, visit: https://fingermotion.com/ […]